Login
$TLSI
$3.80 +$0.18 (4.97%) Close

$TLSI SEC Filings

Filed On Filing
07 Oct 2026 Form 4: Cox Bryan F., Chief of Research

Sold 296 shares ($1.3K)

07 Oct 2026 Form 4: Marshak Richard, Chief Commercial Officer

Sold 325 shares ($1.43K)

07 Oct 2026 Form 4: Stevens Jennifer, Chief Regulatory Officer

Sold 316 shares ($1.39K)

07 Oct 2026 Form 4: Szela Mary T, Director

Gave up 2,693 shares to cover exercise price or tax ($11.8K)

22 Sep 2026 8-K: Other Events

TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug DeliveryTM (PEDDTM) Portfolio for Liver Embolization

06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition
07 Jul 2026 SCHEDULE 13G/A
06 Jul 2026 Form 4: Patience David, Chief Financial Officer

Gave up 14,650 shares to cover exercise price or tax ($65.3K)

01 Jul 2026 Form 4: Szela Mary T, Director

Received 3,990 shares as a grant or award ($15.4K)

01 Jul 2026 Form 5: Szela Mary T, Director

Received 3,530 shares as a grant or award ($15K) · Received 2,848 shares as a grant or award ($12K) · Received 2,100 shares as a grant or award ($9.2K)

01 Jul 2026 Form 4: Marshak Richard, Chief Commercial Officer

Received 561 shares as a grant or award ($2.17K)

01 Jul 2026 Form 5: Marshak Richard, Chief Commercial Officer

Received 279 shares as a grant or award ($1.31K) · Received 999 shares as a grant or award ($4.26K) · Received 930 shares as a grant or award ($3.93K) · 1 more

29 Jun 2026 Form 4: Marshall Richard Henry, Chief Medical Officer

Received 60,000 shares as a grant or award · Granted 120,000 Employee Stock Option (right to buy)

29 Jun 2026 Form 3: Marshall Richard Henry, Chief Medical Officer

Holds 30,000 shares of Common Stock

20 May 2026 SCHEDULE 13G/A
19 May 2026 Form 4: Marshak Richard, Chief Commercial Officer

Sold 543 shares ($1.45K)

18 May 2026 Form 4: Wahlstrom Mats, Director

Bought 60,000 shares ($152K)

18 May 2026 Form 4: Stansky Michael P, Director

Bought 610,000 shares ($1.53M)

18 May 2026 Form 4: Szela Mary T, Director

Bought 39,682 shares ($103K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support